Fig. 1From: Performance of cell-free DNA sequencing-based non-invasive prenatal testing: experience on 36,456 singleton and multiple pregnanciesOutcomes of pregnancies with high-risk and low-risk cfDNA screening results. TOP, termination of pregnancy; NT, nuchal translucencyBack to article page